Ahmad Salehi, M.D, Ph.D. - Publications

Affiliations: 
Psychiatry Stanford Medical School/Palo Alto VA 
Area:
Alzheimer's disease, Down syndrome, NGF, Axonal transport
Website:
http://www.ahmadsalehi.info

72 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Ponnusamy R, McNerney W, Moghadam S, Salehi A. Assessing disease-modifying effects of norepinephrine in Down syndrome and Alzheimer's disease. Brain Research. PMID 29102776 DOI: 10.1016/j.brainres.2017.09.035  1
2017 Ghasemi M, Phillips C, Fahimi A, McNerney MW, Salehi A. Mechanisms of action and clinical efficacy of NMDA receptor modulators in mood disorders. Neuroscience and Biobehavioral Reviews. PMID 28711661 DOI: 10.1016/j.neubiorev.2017.07.002  1
2016 Mojabi FS, Fahimi A, Moghadam S, Moghadam S, McNerneny MW, Ponnusamy R, Kleschevnikov A, Mobley WC, Salehi A. GABAergic Hyperinnervation of Dentate Granule Cells in the Ts65Dn Mouse Model of Down Syndrome Exploring the Role of App. Hippocampus. PMID 27701794 DOI: 10.1002/hipo.22664  1
2016 Fahimi A, Baktir MA, Moghadam S, Mojabi FS, Sumanth K, McNerney MW, Ponnusamy R, Salehi A. Physical exercise induces structural alterations in the hippocampal astrocytes: exploring the role of BDNF-TrkB signaling. Brain Structure & Function. PMID 27686571 DOI: 10.1007/s00429-016-1308-8  1
2016 Phillips C, Salehi A. A Special Regenerative Rehabilitation and Genomics Letter: Is There a "Hope" Molecule? Physical Therapy. 96: 581-3. PMID 27037293 DOI: 10.2522/ptj.2016.96.4.581  0.8
2016 Phillips C, Fahimi A, Das D, Mojabi FS, Ponnusamy R, Salehi A. Noradrenergic system in down syndrome and Alzheimer’s disease a target for therapy Current Alzheimer Research. 13: 68-83.  1
2016 Salehi A, Ashford JW, Mufson EJ. The link between alzheimer’s disease and down syndrome. A historical perspective Current Alzheimer Research. 13: 2-6.  1
2015 Phillips C, Fahimi A, Das D, Mojabi FS, Ponnusamy R, Salehi A. Noradrenergic System in Down Syndrome and Alzheimer's Disease A Target for Therapy. Current Alzheimer Research. PMID 26391048  1
2015 Das D, Medina B, Baktir MA, Mojabi FS, Fahimi A, Ponnusamy R, Salehi A. Increased incidence of intermittent hypoxemia in the Ts65Dn mouse model of Down syndrome. Neuroscience Letters. 604: 91-6. PMID 26240993 DOI: 10.1016/j.neulet.2015.07.040  1
2015 Belichenko PV, Kleschevnikov AM, Becker A, Wagner GE, Lysenko LV, Yu YE, Mobley WC. Down Syndrome Cognitive Phenotypes Modeled in Mice Trisomic for All HSA 21 Homologues. Plos One. 10: e0134861. PMID 26230397 DOI: 10.1371/journal.pone.0134861  0.96
2015 Das D, Phillips C, Lin B, Mojabi F, Akif Baktir M, Dang V, Ponnusamy R, Salehi A. Assessment of dendritic arborization in the dentate gyrus of the hippocampal region in mice. Journal of Visualized Experiments : Jove. PMID 25867799 DOI: 10.3791/52371  1
2015 Nosheny RL, Belichenko PV, Busse BL, Weissmiller AM, Dang V, Das D, Fahimi A, Salehi A, Smith SJ, Mobley WC. Increased cortical synaptic activation of TrkB and downstream signaling markers in a mouse model of Down Syndrome. Neurobiology of Disease. 77: 173-90. PMID 25753471 DOI: 10.1016/j.nbd.2015.02.022  1
2015 Phillips C, Akif Baktir M, Das D, Lin B, Salehi A. The Link Between Physical Activity and Cognitive Dysfunction in Alzheimer Disease. Physical Therapy. 95: 1046-60. PMID 25573757 DOI: 10.2522/ptj.20140212  0.8
2015 Das D, Medina B, Baktir MA, Mojabi FS, Fahimi A, Ponnusamy R, Salehi A. Increased incidence of intermittent hypoxemia in the Ts65Dn mouse model of Down syndrome Neuroscience Letters. 604: 91-96. DOI: 10.1016/j.neulet.2015.07.040  1
2014 Heller HC, Salehi A, Chuluun B, Das D, Lin B, Moghadam S, Garner CC, Colas D. Nest building is impaired in the Ts65Dn mouse model of Down syndrome and rescued by blocking 5HT2a receptors. Neurobiology of Learning and Memory. 116: 162-71. PMID 25463650 DOI: 10.1016/j.nlm.2014.10.002  1
2014 Ghasemi M, Phillips C, Trillo L, De Miguel Z, Das D, Salehi A. The role of NMDA receptors in the pathophysiology and treatment of mood disorders. Neuroscience and Biobehavioral Reviews. 47: 336-58. PMID 25218759 DOI: 10.1016/j.neubiorev.2014.08.017  0.88
2014 Phillips C, Baktir MA, Srivatsan M, Salehi A. Neuroprotective effects of physical activity on the brain: a closer look at trophic factor signaling. Frontiers in Cellular Neuroscience. 8: 170. PMID 24999318 DOI: 10.3389/fncel.2014.00170  1
2014 Das D, Phillips C, Hsieh W, Sumanth K, Dang V, Salehi A. Neurotransmitter-based strategies for the treatment of cognitive dysfunction in Down syndrome. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 54: 140-8. PMID 24842803 DOI: 10.1016/j.pnpbp.2014.05.004  1
2014 Dang V, Medina B, Das D, Moghadam S, Martin KJ, Lin B, Naik P, Patel D, Nosheny R, Wesson Ashford J, Salehi A. Formoterol, a long-acting β2 adrenergic agonist, improves cognitive function and promotes dendritic complexity in a mouse model of Down syndrome. Biological Psychiatry. 75: 179-88. PMID 23827853 DOI: 10.1016/j.biopsych.2013.05.024  1
2013 Trillo L, Das D, Hsieh W, Medina B, Moghadam S, Lin B, Dang V, Sanchez MM, De Miguel Z, Ashford JW, Salehi A. Ascending monoaminergic systems alterations in Alzheimer's disease. translating basic science into clinical care. Neuroscience and Biobehavioral Reviews. 37: 1363-79. PMID 23707776 DOI: 10.1016/j.neubiorev.2013.05.008  1
2012 Kleschevnikov AM, Belichenko PV, Salehi A, Wu C. Discoveries in Down syndrome: moving basic science to clinical care. Progress in Brain Research. 197: 199-221. PMID 22541294 DOI: 10.1016/B978-0-444-54299-1.00010-8  1
2012 Kleschevnikov AM, Belichenko PV, Gall J, George L, Nosheny R, Maloney MT, Salehi A, Mobley WC. Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome. Neurobiology of Disease. 45: 683-91. PMID 22062771 DOI: 10.1016/j.nbd.2011.10.009  1
2012 Millan Sanchez M, Heyn SN, Das D, Moghadam S, Martin KJ, Salehi A. Neurobiological elements of cognitive dysfunction in down syndrome: exploring the role of APP. Biological Psychiatry. 71: 403-9. PMID 21945306 DOI: 10.1016/j.biopsych.2011.08.016  1
2011 Sanchez MM, Das D, Taylor JL, Noda A, Yesavage JA, Salehi A. BDNF polymorphism predicts the rate of decline in skilled task performance and hippocampal volume in healthy individuals. Translational Psychiatry. 1: e51. PMID 22833197 DOI: 10.1038/tp.2011.47  1
2011 Sanchez MM, Moghadam S, Naik P, Martin KJ, Salehi A. Hippocampal network alterations in Alzheimer's disease and Down syndrome: from structure to therapy. Journal of Alzheimer's Disease : Jad. 26: 29-47. PMID 21971449 DOI: 10.3233/JAD-2011-0050  1
2011 Ashford JW, Salehi A, Furst A, Bayley P, Frisoni GB, Jack CR, Sabri O, Adamson MM, Coburn KL, Olichney J, Schuff N, Spielman D, Edland SD, Black S, Rosen A, et al. Imaging the Alzheimer brain. Journal of Alzheimer's Disease : Jad. 26: 1-27. PMID 21971448 DOI: 10.3233/JAD-2011-0073  1
2011 Zhan K, Xie H, Gall J, Ma M, Griesbeck O, Salehi A, Rao J. Real-time imaging of Rab5 activity using a prequenched biosensor. Acs Chemical Biology. 6: 692-9. PMID 21506516 DOI: 10.1021/cb100377m  1
2011 DeLorey TM, Sahbaie P, Hashemi E, Li WW, Salehi A, Clark DJ. Somatosensory and sensorimotor consequences associated with the heterozygous disruption of the autism candidate gene, Gabrb3. Behavioural Brain Research. 216: 36-45. PMID 20699105 DOI: 10.1016/j.bbr.2010.06.032  1
2011 Wesson Ashford J, Salehi A, Furst A, Bayley P. Section 1: Introduction to imaging the Alzheimer brain: The pathology and pathophysiological bases of Alzheimer's disease: Implications for advancing diagnostic imaging Advances in Alzheimer's Disease. 2: 3-10. DOI: 10.3233/978-1-60750-793-2-3  1
2011 Sanchez MM, Moghadam S, Naik P, Martin KJ, Salehi A. Hippocampal network alterations in Alzheimer's disease and downsyndrome: From structure to therapy Advances in Alzheimer's Disease. 2: 11-29. DOI: 10.3233/978-1-60750-793-2-11  1
2009 Salehi A, Faizi M, Colas D, Valletta J, Laguna J, Takimoto-Kimura R, Kleschevnikov A, Wagner SL, Aisen P, Shamloo M, Mobley WC. Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome. Science Translational Medicine. 1: 7ra17. PMID 20368182 DOI: 10.1126/scitranslmed.3000258  1
2009 Tamaki SJ, Jacobs Y, Dohse M, Capela A, Cooper JD, Reitsma M, He D, Tushinski R, Belichenko PV, Salehi A, Mobley W, Gage FH, Huhn S, Tsukamoto AS, Weissman IL, et al. Neuroprotection of host cells by human central nervous system stem cells in a mouse model of infantile neuronal ceroid lipofuscinosis. Cell Stem Cell. 5: 310-9. PMID 19733542 DOI: 10.1016/j.stem.2009.05.022  1
2009 Honda M, Arai T, Fukazawa M, Honda Y, Tsuchiya K, Salehi A, Akiyama H, Mignot E. Absence of ubiquitinated inclusions in hypocretin neurons of patients with narcolepsy. Neurology. 73: 511-7. PMID 19687452 DOI: 10.1212/WNL.0b013e3181b2a6af  1
2009 Peng S, Garzon DJ, Marchese M, Klein W, Ginsberg SD, Francis BM, Mount HT, Mufson EJ, Salehi A, Fahnestock M. Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 9321-9. PMID 19625522 DOI: 10.1523/JNEUROSCI.4736-08.2009  1
2009 Cartier AE, Djakovic SN, Salehi A, Wilson SM, Masliah E, Patrick GN. Regulation of synaptic structure by ubiquitin C-terminal hydrolase L1. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 7857-68. PMID 19535597 DOI: 10.1523/JNEUROSCI.1817-09.2009  0.36
2009 Belichenko NP, Belichenko PV, Kleschevnikov AM, Salehi A, Reeves RH, Mobley WC. The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 5938-48. PMID 19420260 DOI: 10.1523/JNEUROSCI.1547-09.2009  1
2009 Honda M, Eriksson KS, Zhang S, Tanaka S, Lin L, Salehi A, Hesla PE, Maehlen J, Gaus SE, Yanagisawa M, Sakurai T, Taheri S, Tsuchiya K, Honda Y, Mignot E. IGFBP3 colocalizes with and regulates hypocretin (orexin). Plos One. 4: e4254. PMID 19158946 DOI: 10.1371/journal.pone.0004254  1
2009 Belichenko PV, Kleschevnikov AM, Masliah E, Wu C, Takimoto-Kimura R, Salehi A, Mobley WC. Excitatory-inhibitory relationship in the fascia dentata in the Ts65Dn mouse model of Down syndrome. The Journal of Comparative Neurology. 512: 453-66. PMID 19034952 DOI: 10.1002/cne.21895  1
2007 Salehi A, Faizi M, Belichenko PV, Mobley WC. Using mouse models to explore genotype-phenotype relationship in Down syndrome. Mental Retardation and Developmental Disabilities Research Reviews. 13: 207-14. PMID 17910089 DOI: 10.1002/mrdd.20164  1
2007 Belichenko PV, Kleschevnikov AM, Salehi A, Epstein CJ, Mobley WC. Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationships. The Journal of Comparative Neurology. 504: 329-45. PMID 17663443 DOI: 10.1002/cne.21433  1
2007 Salehi A, Kleshevnikov A, Mobley WC. Cholinergic neurodegeneration in Alzheimer's disease: Basis for nerve growth factor therapy Pharmacological Mechanisms in Alzheimer's Therapeutics. 64-104. DOI: 10.1007/978-0-387-71522-3_5  1
2006 Salehi A, Delcroix JD, Belichenko PV, Zhan K, Wu C, Valletta JS, Takimoto-Kimura R, Kleschevnikov AM, Sambamurti K, Chung PP, Xia W, Villar A, Campbell WA, Kulnane LS, Nixon RA, et al. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron. 51: 29-42. PMID 16815330 DOI: 10.1016/j.neuron.2006.05.022  1
2004 Belichenko PV, Masliah E, Kleschevnikov AM, Villar AJ, Epstein CJ, Salehi A, Mobley WC. Synaptic structural abnormalities in the Ts65Dn mouse model of Down Syndrome. The Journal of Comparative Neurology. 480: 281-98. PMID 15515178 DOI: 10.1002/cne.20337  1
2004 Yesavage JA, Friedman L, Kraemer H, Tinklenberg JR, Salehi A, Noda A, Taylor JL, O'Hara R, Murphy G. Sleep/wake disruption in Alzheimer's disease: APOE status and longitudinal course. Journal of Geriatric Psychiatry and Neurology. 17: 20-4. PMID 15018693 DOI: 10.1177/0891988703261994  1
2004 Salehi A, Delcroix JD, Swaab DF. Alzheimer's disease and NGF signaling. Journal of Neural Transmission (Vienna, Austria : 1996). 111: 323-45. PMID 14991458 DOI: 10.1007/s00702-003-0091-x  1
2004 Delcroix JD, Valletta J, Wu C, Howe CL, Lai CF, Cooper JD, Belichenko PV, Salehi A, Mobley WC. Trafficking the NGF signal: implications for normal and degenerating neurons. Progress in Brain Research. 146: 3-23. PMID 14699953  1
2003 Salehi A, Delcroix JD, Mobley WC. Traffic at the intersection of neurotrophic factor signaling and neurodegeneration. Trends in Neurosciences. 26: 73-80. PMID 12536130 DOI: 10.1016/S0166-2236(02)00038-3  1
2002 Verwer RW, Hermens WT, Dijkhuizen P, ter Brake O, Baker RE, Salehi A, Sluiter AA, Kok MJ, Muller LJ, Verhaagen J, Swaab DF. Cells in human postmortem brain tissue slices remain alive for several weeks in culture. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 16: 54-60. PMID 11772936 DOI: 10.1096/fj.01-0504com  1
2001 Cooper JD, Salehi A, Delcroix JD, Howe CL, Belichenko PV, Chua-Couzens J, Kilbridge JF, Carlson EJ, Epstein CJ, Mobley WC. Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion. Proceedings of the National Academy of Sciences of the United States of America. 98: 10439-44. PMID 11504920 DOI: 10.1073/pnas.181219298  1
2000 van Leeuwen FW, Fischer DF, Kamel D, Sluijs JA, Sonnemans MA, Benne R, Swaab DF, Salehi A, Hol EM. Molecular misreading: a new type of transcript mutation expressed during aging. Neurobiology of Aging. 21: 879-91. PMID 11124436 DOI: 10.1016/S0197-4580(00)00151-2  1
2000 Ishunina TA, Salehi A, Swaab DF. Sex- and age-related P75 neurotrophin receptor expression in the human supraoptic nucleus. Neuroendocrinology. 71: 243-51. PMID 10773744  1
2000 Salehi A, Ocampo M, Verhaagen J, Swaab DF. P75 neurotrophin receptor in the nucleus basalis of meynert in relation to age, sex, and Alzheimer's disease. Experimental Neurology. 161: 245-58. PMID 10683291 DOI: 10.1006/exnr.1999.7252  1
1999 Salehi A, Swaab DF. Diminished neuronal metabolic activity in Alzheimer's disease. Review article. Journal of Neural Transmission (Vienna, Austria : 1996). 106: 955-86. PMID 10599878 DOI: 10.1007/s007020050216  1
1999 Ishunina TA, Salehi A, Hofman MA, Swaab DF. Activity of vasopressinergic neurones of the human supraoptic nucleus is age- and sex-dependent. Journal of Neuroendocrinology. 11: 251-8. PMID 10223278 DOI: 10.1046/j.1365-2826.1999.00318.x  1
1998 Salehi A, Pool CW, Mulder M, Ravid R, Gonatas NK, Swaab DF. Activity of Hippocampal CA1 Neurons in Alzheimer's Disease is not Affected by the Presence of Adjacent Neuritic Plaques. Journal of Alzheimer's Disease : Jad. 1: 107-118. PMID 12214007  1
1998 Salehi A, Gonzalez Martinez V, Swaab DF. A sex difference and no effect of ApoE type on the amount of cytoskeletal alterations in the nucleus basalis of Meynert in Alzheimer's disease. Neurobiology of Aging. 19: 505-10. PMID 10192208 DOI: 10.1016/S0197-4580(98)00106-7  1
1998 Swaab DF, Lucassen PJ, Salehi A, Scherder EJ, van Someren EJ, Verwer RW. Reduced neuronal activity and reactivation in Alzheimer's disease. Progress in Brain Research. 117: 343-77. PMID 9932420  1
1998 Salehi A, Verhaagen J, Swaab DF. Neurotrophin receptors in Alzheimer's disease. Progress in Brain Research. 117: 71-89. PMID 9932402  1
1998 Salehi A, Dubelaar EJ, Mulder M, Swaab DF. Aggravated decrease in the activity of nucleus basalis neurons in Alzheimer's disease is apolipoprotein E-type dependent. Proceedings of the National Academy of Sciences of the United States of America. 95: 11445-9. PMID 9736756 DOI: 10.1073/pnas.95.19.11445  1
1998 Salehi A, Bakker JM, Mulder M, Swaab DF. Limited effect of neuritic plaques on neuronal density in the hippocampal CA1 area of Alzheimer patients. Alzheimer Disease and Associated Disorders. 12: 77-82. PMID 9651135  1
1998 Oleana VH, Salehi A, Swaab DF. Increased expression of the TIAR protein in the hippocampus of Alzheimer patients. Neuroreport. 9: 1451-4. PMID 9631446  1
1998 van Leeuwen FW, de Kleijn DP, van den Hurk HH, Neubauer A, Sonnemans MA, Sluijs JA, Köycü S, Ramdjielal RD, Salehi A, Martens GJ, Grosveld FG, Peter J, Burbach H, Hol EM. Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science (New York, N.Y.). 279: 242-7. PMID 9422699 DOI: 10.1126/science.279.5348.242  1
1998 Van Leeuwen F, Salehi A, Giger R, Holtmaat A, Verhaagen J, Eikelboom T, Verweij W, Top W. Neuronal degeneration and regeneration: From basic mechanisms to prospects for therapy - Proceedings of the 20th International Summer School of Brain Research, held at the Royal Netherlands Academy of Sciences, Amsterdam, The Netherlands from 25 to 29 August 1997: Preface Progress in Brain Research. 117: xi-xii.  1
1997 Lucassen PJ, Tilders FJ, Salehi A, Swaab DF. Neuropeptides vasopressin (AVP), oxytocin (OXT) and corticotropin-releasing hormone (CRH) in the human hypothalamus: activity changes in aging, Alzheimer's disease and depression. Aging (Milan, Italy). 9: 48-50. PMID 9358882  1
1997 Swaab DF, Salehi A. The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. Journal of Neuropathology and Experimental Neurology. 56: 216. PMID 9034377  1
1996 Salehi A, Verhaagen J, Dijkhuizen PA, Swaab DF. Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease. Neuroscience. 75: 373-87. PMID 8931004 DOI: 10.1016/0306-4522(96)00273-4  1
1995 Salehi A, Ravid R, Gonatas NK, Swaab DF. Decreased activity of hippocampal neurons in Alzheimer's disease is not related to the presence of neurofibrillary tangles. Journal of Neuropathology and Experimental Neurology. 54: 704-9. PMID 7666060  1
1995 Salehi A, Van de Nes JA, Hofman MA, Gonatas NK, Swaab DF. Early cytoskeletal changes as shown by Alz-50 are not accompanied by decreased neuronal activity. Brain Research. 678: 28-39. PMID 7620896 DOI: 10.1016/0006-8993(95)00138-G  1
1995 Salehi A, Heyn S, Gonatas NK, Swaab DF. Decreased protein synthetic activity of the hypothalamic tuberomamillary nucleus in Alzheimer's disease as suggested by smaller Golgi apparatus. Neuroscience Letters. 193: 29-32. PMID 7566659 DOI: 10.1016/0304-3940(95)11659-K  1
1994 Salehi A, Lucassen PJ, Pool CW, Gonatas NK, Ravid R, Swaab DF. Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus. Neuroscience. 59: 871-80. PMID 8058125 DOI: 10.1016/0306-4522(94)90291-7  1
1994 Swaab DF, Hofman MA, Lucassen PJ, Salehi A, Uylings HB. Neuronal atrophy, not cell death, is the main hallmark of Alzheimer's disease. Neurobiology of Aging. 15: 369-71; discussion 3. PMID 7936066 DOI: 10.1016/0197-4580(94)90037-X  1
1994 Lucassen PJ, Salehi A, Pool CW, Gonatas NK, Swaab DF. Activation of vasopressin neurons in aging and Alzheimer's disease. Journal of Neuroendocrinology. 6: 673-9. PMID 7894470 DOI: 10.1111/j.1365-2826.1994.tb00634.x  1
Show low-probability matches.